Clinical Trial Results

Showing: All studies [change]
Condition: Diabetes Location: Cumberland, Rhode Island 25 trials found
New Search
Filter
Trial Phase
Study Type
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
PHASE4INTERVENTIONAL Huntsville, Alabama +4 more
RECRUITING
The Effects of a Low Glycemic Load Diet on Dysglycemia and Body Composition in Adults With Cystic Fibrosis-Related Diabetes
NAINTERVENTIONAL Boston, Massachusetts +1 more
RECRUITING
Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 Diabetes
NAINTERVENTIONAL Durham, North Carolina +1 more
RECRUITING
Lifestyle Interventions to Prevent Diabetes in U.S. Home Visiting Programs
NAINTERVENTIONAL San Luis Obispo, California +2 more
RECRUITING
Type 1 Diabetes Adolescents for Healthier Lifestyles Study
NAINTERVENTIONAL Providence, Rhode Island
RECRUITING
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
PHASE2INTERVENTIONAL Mobile, Alabama +4 more
RECRUITING
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
PHASE4INTERVENTIONAL Tuscaloosa, Alabama +4 more
RECRUITING
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
PHASE3INTERVENTIONAL Sun City, Arizona +4 more
RECRUITING
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
PHASE2INTERVENTIONAL Huntsville, Alabama +4 more
RECRUITING
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
PHASE2INTERVENTIONAL Canoga Park, California +4 more
RECRUITING
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
PHASE3INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
PHASE3INTERVENTIONAL Cullman, Alabama +4 more
RECRUITING
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
PHASE3INTERVENTIONAL Glendale, Arizona +4 more
RECRUITING
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
PHASE2INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
Personalized Responses to Dietary Composition Trial 3
NAINTERVENTIONAL Needham, Massachusetts +1 more
RECRUITING
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
Continuous Glucose Monitor Use in Pregnancy
NAINTERVENTIONAL Worcester, Massachusetts
RECRUITING
Re-Engineered Discharge for Diabetes Care Transitions
NAINTERVENTIONAL Worcester, Massachusetts
RECRUITING
Early Detection of Gestational Diabetes Mellitus in Pregnancy
NAINTERVENTIONAL Worcester, Massachusetts
RECRUITING
Social Needs Screening and Chronic Diseases Study (WE CARE)
NAINTERVENTIONAL Worcester, Massachusetts +2 more
RECRUITING
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
PHASE3INTERVENTIONAL Tuscaloosa, Alabama +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type